Abstract
The Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), also known as CD66a, is a member of the immunoglobulin superfamily. CEACAM1 was shown to be a prognostic marker in patients suffering from cancer. In this review, we summarize pre-clinical and clinical evidence linking CEACAM1 to tumorigenicity and cancer progression. Furthermore, we discuss potential CEACAM1-based mechanisms that may affect cancer biology.
Keywords:
CEA; CEACAM1; cancer; malignancy; metastasis; signaling; tumor.
Copyright © 2023 Götz, Rueckschloss, Balk, Pfeiffer, Ergün and Kleefeldt.
Publication types
-
Review
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, CD / metabolism
-
CEACAM1 Protein
-
Carcinoembryonic Antigen / metabolism
-
Cell Adhesion Molecules* / metabolism
-
Humans
-
Neoplasms*
Substances
-
Antigens, CD
-
Carcinoembryonic Antigen
-
CEACAM1 Protein
-
Cell Adhesion Molecules
-
CD66 antigens
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Walter Schulz Foundation (Planegg, Germany) and the Cancer Research Advancement Foundation (Forschung hilft) at the University of Würzburg (Würzburg, Germany).